Drug Topics
MAY 21, 2024
Research presented at Digestive Disease Week suggests that including omega-3 rich foods, or omega-3 supplements, into a healthy diet could offer additional protection against colorectal cancer alongside regular screening.
PharmaVoice
MAY 21, 2024
These three U.S. cities are putting themselves on the biotech map as unsung hubs of the industry.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Drug Topics
MAY 21, 2024
Unregulated tianeptine, often referred to as “gas station heroin,” has led to serious adverse effects. But while health officials warn the public about its potential dangers, others are concerned stigmatization could ruin any future chance of the drugs medicinal use.
STAT
MAY 21, 2024
Scientists from the University of Washington and the Fred Hutchinson Cancer Center have managed to generate a full genetic sequence of H5N1 virus from milk, a development they suggest means commercially purchased milk products could be used to monitor the progress of the bird flu outbreak in dairy cattle and to check for important changes in the virus over time.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Drug Topics
MAY 21, 2024
Research presented at DDW 2024 found there was no significant association between immune response and hepatitis B vaccine types in patients with Hepatitis C.
STAT
MAY 21, 2024
BATON ROUGE, La. — The surgery was supposed to alleviate worry, but now, years later, Whitney Carter’s mind kept flicking back to it, wondering if it could be undone. She sometimes descended into these moods, taciturn, withdrawn, as if all hope had gone extinct. She sat on the couch in the half-light, blinds shut against the heat. The whole thing made her feel less than, like some essential part of her had been removed.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
STAT
MAY 21, 2024
The Centers for Disease Control and Prevention asked local and state health officials Tuesday to maintain flu surveillance operations at peak-season levels over the summer in a bid to remain watchful for any signs of human-to-human spread of the H5N1 bird flu virus. Flu surveillance activity is generally conducted at low levels during the late spring and summer months, in recognition of the fact that as temperatures rise, transmission of seasonal flu viruses drops to minimal levels in the Northe
Drug Topics
MAY 21, 2024
Berdazimer topical gel is the first in its class and is the only topical prescription medication to treat molluscum contagiosium that can be applied by patients or caregivers outside of a medical setting.
Pharmacy Times
MAY 21, 2024
Inavolisib was submitted to the FDA for review as a first-line treatment for advanced HR-positive, HER2-negative PIK3CA-mutated breast cancer.
Drug Topics
MAY 21, 2024
Beyond improving glucose control, hybrid closed-loop glucose monitoring systems offered indirect benefits like reduced fear of hypoglycemia and improved sleep quality among youth with type 1 diabetes (T1D).
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Pharmacy Times
MAY 21, 2024
Aligning community pharmacy interventions with top-down findings, payers’ population health priorities, and identified unmet needs can help develop a sustainable pathway.
STAT
MAY 21, 2024
Hundreds of genetic variants can nudge someone’s risk of breast cancer up or down or towards a particular subtype. The studies identifying those gene variants, though, have largely involved people with European ancestry and thus give a less accurate picture of breast cancer risk for people who are not white. That’s beginning to change.
Pharmacy Times
MAY 21, 2024
As value-based health care models become more widespread, these types of interventions will be important to demonstrate the value of pharmacist-embedded HSSPs.
STAT
MAY 21, 2024
I am both excited and terrified by the entrance of artificial intelligence into my primary care practice. AI’s enormous potential to help clinicians become more focused on patients, available, diagnostically accurate, and efficient feels like a dream. Yet memories of the nightmarish introduction of the electronic heath record into clinicians’ work lives looms like a dark cloud.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Pharmacy Times
MAY 21, 2024
Researchers from the University of Leipzig Medical Center identify multiple biomarkers associated with the success of CAR T cell therapy in relapsed multiple myeloma.
STAT
MAY 21, 2024
CAMBRIDGE, England — On a bit of a roll, AstraZeneca on Tuesday laid out ambitious growth goals for the rest of the decade, seeking to build on its momentum in fields like oncology as it said it would nearly double its revenue to $80 billion by 2030. Hitting such a target would depend on the launch of 20 new medicines and continued growth of its cancer and rare disease therapies, as well as other drugs.
Pharmacy Times
MAY 21, 2024
The results showed that individuals treated with milvexian had a prolonged aPTT in a dose-dependent manner with limited effects of PT.
Fierce Healthcare
MAY 21, 2024
A new paper published in the Journal of Cardiac Failure shows that patients on Cadence’s remote physiologic monitoring program had better outcomes than patients eligible for the program wh | Deaths from heart failure are rising. National remote monitoring company Cadence published new evidence that RM for heart failure with reduced ejection fraction (HFrEF) could be the missing link in heart failure treatment.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
STAT
MAY 21, 2024
“Telehealth is collapsing.” “Telehealth is going through a contraction.” “There is a dark cloud hovering over virtual care.” These are just a few of the doomsday views sparked by the news that Optum and Walmart are shutting down their virtual care businesses. Many industry observers, connecting the dots to the current struggles of legacy telehealth providers , have concluded that virtual care is in trouble.
Pharmacy Times
MAY 21, 2024
Results from the INCREASE study shed light on the value of the pharmacist in medication therapy management.
STAT
MAY 21, 2024
A new asthma treatment that could be administered just once every six months has succeeded in two Phase 3 trials, developer GlaxoSmithKline announced Tuesday. The drug, depemokimab, is designed to treat asthma by targeting a protein called interleukin-5, or IL-5. The protein is linked to the type of inflammation found in most severe asthma cases, according to the pharma company.
PharmaVoice
MAY 21, 2024
Heather Dean discusses the company’s neuroscience pipeline in epilepsy and narcolepsy and moving from a mass market to a rare disease mentality.
STAT
MAY 21, 2024
Dear Readers, I want to bring your attention to a deeply disturbing but vital series of stories STAT is publishing beginning today. It reveals that an injustice often relegated to the distant past persists to this day: For decades, physicians have steered sickle cell patients toward sterilization, their stories echoing the ugly history of eugenics in America.
Fierce Healthcare
MAY 21, 2024
Three years after talks of an IPO surfaced, health tech company Tempus AI lit the fuse and is looking to go public this year. | Founded in 2015, Tempus says it’s built the world’s largest library of clinical and molecular data along with an operating system to make those data accessible and useful for providers to inform patient care.
Pharmacy Times
MAY 21, 2024
Investigators assessed the efficacy of BsAb5003 in treating multiple myeloma, with the results showing that the therapy may be an effective treatment approach.
STAT
MAY 21, 2024
Checkpoint inhibitors, drugs that unleash the immune system, have turned into blockbuster therapies that have transformed outcomes for some patients with deadly cancers. AltruBio, a Bay Area biotech, is betting it can help patients suffering from autoimmune and inflammatory diseases by taking the opposite tack: pumping the brakes on runaway immune responses.
Pharmacy Times
MAY 21, 2024
The primary outcome was a 90-day incidence of mortality or liver transplant for individuals who received larsucosterol, compared to the placebo group.
pharmaphorum
MAY 21, 2024
AstraZeneca CEO Pascal Soriot says group revenues can reach $80bn by 2030, fuelled by a pipeline that features 'many' potential $5bn-plus candidates.
STAT
MAY 21, 2024
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Good morning. Please take some time today to read this story from my colleague Eric Boodman, who spent a year investigating how doctors are pushing sickle cell patients to get unwanted sterilizations. This is the first story in a new series from STAT called Coercive Care.
pharmaphorum
MAY 21, 2024
FDA is asking artificial intelligence teams to develop a digital endpoint tool to study freezing of gait, a symptom of Parkinson’s that can have a serious impact on patients.
PioneerRx
MAY 21, 2024
As independent pharmacy continues to go clinical, you’ve probably found yourself considering adding a service, expanding a program, or in this case, tacking on.
pharmaphorum
MAY 21, 2024
In today’s podcast, web editor Nicole Raleigh speaks with PASQAL’S technical business developer Europe, Krisztian Benyo, PhD, about the pharma applications and commercialisation of quantum science.
STAT
MAY 21, 2024
Good morning from the Pharmalittle campus, where I’m filling in for Ed. Normally, I’m the type of person who used to press snooze 10 times in their dorm room before running across campus to arrive for class barely on time. But this week, I’m up early. The scent of strong, dark roast espresso is just beginning to travel up my nasal passages to my brain.
Expert insights. Personalized for you.
100 
Let's personalize your content